Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines
- PMID: 26604264
- PMCID: PMC4658589
- DOI: 10.1128/CVI.00497-15
Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines
Comment in
-
Reply to "Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines".Clin Vaccine Immunol. 2015 Dec;22(12):1296-7. doi: 10.1128/CVI.00504-15. Clin Vaccine Immunol. 2015. PMID: 26604265 Free PMC article. No abstract available.
Comment on
-
Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression.Clin Vaccine Immunol. 2015 Jul;22(7):798-805. doi: 10.1128/CVI.00034-15. Epub 2015 May 13. Clin Vaccine Immunol. 2015. PMID: 25972402 Free PMC article.
References
-
- Patel M, Carritt K, Lane J, Jayappa H, Stahl M, Bourgeois M. 2015. Comparative efficacy of feline leukemia virus (FeLV) inactivated whole-virus vaccine and canarypox virus-vectored vaccine during virulent FeLV challenge and immunosuppression. Clin Vaccine Immunol 22:798–805. doi: 10.1128/CVI.00034-15. - DOI - PMC - PubMed
-
- Schlecht-Louf G, Mangeney M, El-Garch H, Lacombe V, Poulet H, Heidmann T. 2014. A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine. J Virol 88:992–1001. doi: 10.1128/JVI.02234-13. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
